Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T6GGB6V" height="0" width="0" style="display:none;visibility:hidden"></iframe> ...

Merck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication ...